Bacterial meningitis

Neurologic Clinics

Volumn 17, Issue 4, 1999, Pages 711-735

  Spach, D H ^a   Jackson, L A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEROPENEM; PENICILLIN G; PNEUMOCOCCUS VACCINE; RIFAMPICIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; ENCEPHALITIS; HAEMOPHILUS INFLUENZAE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE;

EID: 0032702818     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70163-8     Document Type: Article

References (116)

1. Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis J Infect Dis 134 1976 201
2. Control and prevention of meningococcal disease Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 46 1997 1
3. Prevention of perinatal group B streptococcal disease A public health perspective. Centers for Disease Control and Prevention MMWR 45 1996 1
4. Progress toward eliminating Haemophilus influenzae type b disease among infants and children—United States, 1987–1997 MMWR 47 1998 993
5. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine Recommendations of the advisory Committee on Immunization Practices (ACIP) MMWR 42 1993 1
6. Update Foodborne listeriosis—United States, 1988–1990 MMWR 41 1992 251
7. Update Prevention of Haemophilus influenzae type b disease MMWR 35 1986 170
8. W.G. Adams K.A. Deaver S.L. Cochi Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era JAMA 269 1993 221
9. Arditi M. Mason E.O. Jr J.S. Bradley Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use Pediatrics 102 1998 1087
10. F. Asensi M.C. Otero D. Perez-Tamarit Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus J Chemother 5 1993 133
11. F. Asensi D. Perez-Tamarit M.C. Otero Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus [letter] Pediatr Infect Dis J 8 1989 895
12. Barenkamp S.J. Munson R.S. Jr D.M. Granoff Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles J Infect Dis 143 1981 668
13. N. Barquet P. Domingo J.A. Cayla Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group JAMA 278 1997 491
14. G. Bjune E.A. Hoiby J.K. Gronnesby Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway Lancet 338 1991 1093
15. Black S, Shinefield H, Ray P, et al: Efficacy of heptavalent conjugate pneumococcal vaccine in 37,000 infants and children: Results of the Northern California Kaiser Permanente Efficacy Trial. [Abstract LB-9]. In 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA September 24–27, 1998
16. E. Bouvet F. Suter C. Gibert Severe meningitis due to Listeria monocytogenes . A review of 40 cases in adults Scand J Infect Dis 14 1982 267
17. J.S. Bradley J.D. Connor Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics Pediatr Infect Dis J 10 1991 871
18. J.S. Bradley W.M. Scheld The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: Current antibiotic therapy in the 1990s Clin Infect Dis 24 suppl 2 1997 S213
19. C.V. Broome R.R. Facklam Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States Rev Infect Dis 3 1981 277
20. C.V. Broome E.A. Mortimer S.L. Katz Use of chemoprophylaxis to prevent the spread of Hemophilus influenzae B in day-care facilities N Engl J Med 316 1987 1226
21. J.C. Butler Epidemiology of pneumococcal serotypes and conjugate vaccine formulations Microb Drug Resist 3 1997 125
22. J.C. Butler J. Hofmann M.S. Cetron The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System J Infect Dis 174 1996 986
23. C. Cabellos J. Martinez-Lacasa A. Martos Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis Antimicrob Agents Chemother 39 1995 2158
24. G.M. Caputo P.C. Appelbaum H.H. Liu Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features Arch Intern Med 153 1993 1301
25. S.L. Cochi C.V. Broome A.W. Hightower Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment JAMA 253 1985 521
26. Dagan R, Givon N, Yagupsky P, et al: Effect of a 9-valent pneumococcal vaccine conjugated to CRM_{l97} (PncCRM9) on nasopharyngeal (NP) carriage of vaccine type and non-vaccine type S. pneumoniue (Pnc) strains among day care center (DCC) attendees [Abstract G-521. In 38th Interscience Conference of Antimicrobial Agents and Chemotherapy, San Diego, CA September 24-27,1998
27. C.J. Destache C.B. Pakiz A.K. Dash Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis Pharmacotherapy 18 1998 612
28. A. Deveikis V. Schauf M. Mizen Antimicrobial therapy of experimental group B streptococcal infection in mice Antimicrob Agents Chemother 11 1977 817
29. J.R. Dillon M. Pauze K.H. Yeung Spread of penicillinase-producing and transfer plasmids from the gonococcus to Neisseria meningitidis Lancet 1 1983 779
30. G.V. Doern A. Brueggemann Holley H.P. Jr Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study Antimicrob Agents Chemother 40 1996 1208
31. G.V. Doern A.B. Brueggemann G. Pierce Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase- positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study Antimicrob Agents Chemother 41 1997 292
32. C.P. Doit S.P. Bonacorsi A.J. Fremaux In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis Antimicrob Agents Chemother 38 1994 2655
33. M.L. Durand S.B. Calderwood D.J. Weber Acute bacterial meningitis in adults. A review of 493 episodes [see comments] N Engl J Med 328 1993 21
34. Erickson L. De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990–1994 Clin Infect Dis 26 1998 1159
35. M.M. Farley R.C. Harvey T. Stull A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults N Engl J Med 328 1993 1807
36. K. Fassbender S. Ries U. Schminke Inflammatory cytokines in CSF in bacterial meningitis: Association with altered blood flow velocities in basal cerebral arteries J Neurol Neurosurg Psychiatry 61 1996 57
37. D.W. Fleming S.L. Cochi K.L. MacDonald Pasteurized milk as a vehicle of infection in an outbreak of listeriosis N Engl J Med 312 1985 404
38. I.R. Friedland K.P. Klugman Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis Lancet 339 1992 405
39. Friedland I.R. McCracken G.H. Jr Management of infections caused by antibiotic-resistant Streptococcus pneumoniae N Engl J Med 331 1994 377
40. I.R. Friedland M. Paris S. Ehrett Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 37 1993 1630
41. M. Galimand G. Gerbaud M. Guibourdenche High-level chloramphenicol resistance in Neisseria meningitidis N Engl J Med 339 1998 868
42. N. Girgis Y. Sultan Frenck R.W. Jr Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis Pediatr Infect Dis J 17 1998 816
43. M.B. Goetz H. O'Brien J.M. Musser Nosocomial transmission of disease caused by nontypeable strains of Haemophilus influenzae Am J Med 96 1994 342
44. L.Z. Goldani Inducement of Neisseria meningitidis resistance to ampicillin and penicillin in a patient with meningococcemia treated with high doses of ampicillin Clin Infect Dis 26 1998 772
45. P.A. Granato E.A. Jurek L.B. Weiner Biotypes of Haemophilus influenzae: Relationship to clinical source of isolation, serotype, and antibiotic susceptibility Am J Clin Pathol 79 1983 73
46. B.M. Gray G.M.D. Converse Dillon H.C. Jr Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life J Infect Dis 142 1980 923
47. Gray B.M. Dillon H.C. Jr Clinical and epidemiologic studies of pneumococcal infection in children Pediatr Infect Dis J 5 1986 201
48. P.B. Hansen T.H. Jensen S. Lykkegaard Listeria monocytogenes meningitis in adults. Sixteen consecutive cases 1973–1982 Scand J Infect Dis 19 1987 55
49. J.P. Hieber J.D. Nelson A pharmacologic evaluation of penicillin in children with purulent meningitis N Engl J Med 297 1977 410
50. A.J. Howard D. Owens J.M. Musser Cross-infection due to Haemophilus influenzae type b in adults [letter] J Hosp Infect 19 1991 70
51. L.A. Jackson E.R. Alexander C.A. DeBolt Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease Pediatr Infect Dis J 15 1996 992
52. L.A. Jackson R. Hilsdon M.M. Farley Risk factors for group B streptococcal disease in adults Ann Intern Med 123 1995 415
53. L.A. Jackson A. Schuchat M.W. Reeves Serogroup C meningococcal outbreaks in the United States. An emerging threat [see comments] JAMA 273 1995 383
54. L.A. Jackson F.C. Tenover C. Baker Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. Meningococcal Disease Study Group J Infect Dis 169 1994 438
55. D.L. Kasper L.C. Paoletti M.R. Wessels Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine J Clin Invest 98 1996 2308
56. Y.S. Kim Q. Liu L.L. Chow Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae Antimicrob Agents Chemother 41 1997 1186
57. S.M. Kircher M.P. Meyer J.A. Jordan Comparison of a modified DNA hybridization assay with standard culture enrichment for detecting group B streptococci in obstetric patients J Clin Microbiol 34 1996 342
58. M.D. Kleiman G.A. Weinberg J.K. Reynolds Meningitis with beta-lactam-resistant Streptococcus pneumoniae: The need for early repeat lumbar puncture Pediatr Infect Dis J 12 1993 782
59. K.P. Klugman I.R. Friedland J.S. Bradley Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis Antimicrob Agents Chemother 39 1995 1988
60. S.L. Leib Y.S. Kim S.M. Black Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis J Infect Dis 177 1998 692
61. J.M. Lieberman S.S. Chiu V.K. Wong Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial JAMA 275 1996 1499
62. M.J. Linnan L. Mascola X.D. Lou Epidemic listeriosis associated with Mexican-style cheese N Engl J Med 319 1988 823
63. I. Lutsar I.R. Friedland L. Wubbel Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 42 1998 2650
64. N.E. MacDonald S.A. Halperin B.J. Law Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: A randomized controlled trial JAMA 280 1998 1685
65. McCracken G.H. Jr Emergence of resistant Streptococcus pneumoniae: A problem in pediatrics Pediatr Infect Dis J 14 1995 424
66. P.B. McIntyre C.S. Berkey S.M. King Dexamethasone as adjunctive therapy in bacterial meningitis.A meta-analysis of randomized clinical trials since 1988 JAMA 278 1997 925
67. T.V. Murphy J.F. Clements J.A. Breedlove Risk of subsequent disease among day-care contacts of patients with systemic Hemophilus influenzae type B disease N Engl J Med 316 1987 5
68. T.V. Murphy K.E. White P. Pastor Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination JAMA 269 1993 246
69. M.M. Mustafa O. Ramilo G.A. Syrogiannopoulos Induction of meningeal inflammation by outer membrane vesicles of Haemophilus influenzae type b J Infect Dis 159 1989 917
70. E. Mylonakis E.L. Hohmann S.B. Calderwood Central nervous system infection with Listeria monocytogenes . 33 years' experience at a general hospital and review of 776 episodes from the literature Medicine (Baltimore) 77 1998 313
71. C. Ostergaard T.K. Sorensen J.D. Knudsen Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits Antimicrob Agents Chemother 42 1998 1706
72. M.T. Osterholm L.M. Pierson K.E. White The risk of subsequent transmission of Hemophilus influenzae type B disease among children in day care. Results of a two-year statewide prospective surveillance and contact survey N Engl J Med 316 1987 1
73. T.R. Pacheco C.K. Cooper D.J. Hardy Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis Am J Med 102 1997 303
74. M.M. Paris S.M. Hickey M.I. Uscher Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 38 1994 1320
75. M.M. Paris O. Ramilo McCracken G.H. Jr Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae Antimicrob Agents Chemother 39 1995 2171
76. Parke J.C. Jr R. Schneerson J.B. Robbins The attack rate, age incidence, racial distribution, and case fatality rate of Hemophilus influenzae type b meningitis in Mecklenbury County, North Carolina J Pediatr 81 1972 765
77. H.W. Pfister W.M. Scheld Brain injury in bacterial meningitis: Therapeutic implications Curr Opin Neurol 10 1997 254
78. A. Pikis J.A. Donkersloot S. Akram Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae J Antimicrob Chemother 40 1997 105
79. R.W. Pinner A. Schuchat B. Swaminathan Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation The Listeria Study Group. JAMA 267 1992 2046
80. M. Pittman Variation and type specificity in the bacterial species Haemophilus influenzae J Exp Med 53 1931 471
81. V. Quagliarello W.M. Scheld Bacterial meningitis: Pathogenesis, pathophysiology, and progress N Engl J Med 327 1992 864
82. V.J. Quagliarello W.M. Scheld Treatment of bacterial meningitis N Engl J Med 336 1997 708
83. V.J. Quagliarello B. Wispelwey Long W.J. Jr Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor J Clin Invest 87 1991 1360
84. J.A. Racoosin C.G. Whitney C.S. Conover Serogroup Y meningococcal disease in Chicago, 1991–1997 JAMA 280 1998 2094
85. O. Ramilo X. Saez-Llorens J. Mertsola Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation J Exp Med 172 1990 497
86. J. Raymond E. Bingen N. Brahimi Pneumococcal meningitis resistant to penicillin and nosocomial transmission in pediatric hospitals confirmed by genomic analysis Arch Pediatr 3 1996 1239
87. M.R. Reichler A.A. Allphin R.F. Breiman The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio J Infect Dis 166 1992 1346
88. J.B. Robbins R. Schneerson Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D N Engl J Med 323 1990 1415
89. W.M. Scheld R.G. Dacey H.R. Winn Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone J Clin Invest 66 1980 243
90. W.M. Scheld D.D. Fletcher F.N. Fink Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes J Infect Dis 140 1979 287
91. W.F.D. Schlech P.M. Lavigne R.A. Bortolussi Epidemic listeriosis—evidence for transmission by food N Engl J Med 308 1983 203
92. A. Schuchat Epidemiology of group B streptococcal disease in the United States: Shifting paradigms Clin Microbiol Rev 11 1998 497
93. A. Schuchat K.A. Deaver J.D. Wenger Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group JAMA 267 1992 2041
94. A. Schuchat K. Robinson J.D. Wenger Bacterial Meningitis in the United States in 1995 N Engl J Med 337 1997 970
95. B. Schwartz A. Schuchat M.J. Oxtoby Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta JAMA 266 1991 1112
96. S.H. Sell R.E. Merrill E.O. Doyne Long-term sequelae of Hemophilus influenzae meningitis Pediatrics 49 1972 206
97. M.S. Simberkoff N.H. Moldover Rahal J. Jr Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency J Lab Clin Med 95 1980 362
98. M.M. Sloas F.F. Barrett P.J. Chesney Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis Pediatr Infect Dis J 11 1992 662
99. F.S. Southwick D.L. Purich Intracellular pathogenesis of listeriosis N Engl J Med 334 1996 770
100. J.W. Tappero A. Schuchat K.A. Deaver Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts?. The Listeriosis Study Group JAMA 273 1995 1118
101. H.G. Taylor E.L. Mills A. Ciampi The sequelae of Haemophilus influenzae meningitis in school-age children N Engl J Med 323 1990 1657
102. Thornsberry C, Hickey M, Diakun D, et al: Sequential surveillance of antimicrobial resistance in the United States: Streptococcus pneumoniae, Haemophilus influenzae , and Moraxella catarrhalis (1997–1998 vs. 1996–1997). [Abstract E-22]. In 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, California, USA
103. A.R. Tunkel B. Wispelwey W.M. Scheld Bacterial meningitis: Recent advances in pathophysiology and treatment Ann Intern Med 112 1990 610
104. E. Tuomanen H. Liu B. Hengstler The induction of meningeal inflammation by components of the pneumococcal cell wall J Infect Dis 151 1985 859
105. E.I. Tuomanen R. Austrian H.R. Masure Pathogenesis of pneumococcal infection N Engl J Med 332 1995 1280
106. J.H. Tureen R.J. Dworkin S.L. Kennedy Loss of cerebrovascular autoregulation in experimental meningitis in rabbits J Clin Invest 85 1990 577
107. P.A. Uldry T. Kuntzer J. Bogousslavsky Early symptoms and outcome of Listeria monocytogenes rhombencephalitis: 14 adult cases J Neurol 240 1993 235
108. S. Uriz V. Pineda M. Grau Neisseria meningitidis with reduced sensitivity to penicillin: Observations in 10 children Scand J Infect Dis 23 1991 171
109. van Alphen L. van Dam A. P. Bol Types and subtypes of 73 strains of Haemophilus influenzae isolated from patients more than 6 years of age with meningitis in The Netherlands J Infect 15 1987 95
110. P.F. Viladrich F. Gudiol J. Linares Evaluation of vancomycin for therapy of adult pneumococcal meningitis Antimicrob Agents Chemother 35 1991 2467
111. P.F. Viladrich F. Gudiol J. Linares Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci Am J Med 84 1988 839
112. Wallace R.J. Jr D.M. Musher E.J. Septimus Haemophilus influenzae infections in adults: Characterization of strains by serotypes, biotypes, and beta-lactamase production J Infect Dis 144 1981 101
113. J.D. Wenger A.W. Hightower R.R. Facklam Bacterial meningitis in the United States, 1986: Report of a multistate surveillance study. The Bacterial Meningitis Study Group J Infect Dis 162 1990 1316
114. B. Wispelwey E.J. Hansen W.M. Scheld Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitis Infect Immun 57 1989 2559
115. C.R. Woods A.L. Smith B.L. Wasilauskas Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina J Infect Dis 170 1994 453
116. Wubbel L. McCracken G.H. Jr Management of bacterial meningitis: 1998 Pediatr Rev 19 1998 78